This is Dimension 6 of 7 in the Patient Marketing Diligence Framework, a standard for evaluating whether a healthcare target’s patient acquisition is built to last or bought to look good for a sale.
Part 6 of 7 — The Patient Marketing Diligence (PMD) Framework
Here’s a question worth asking in any diligence call: if the person who runs marketing left tomorrow, what would break?
Marketing performance that depends on one person’s undocumented knowledge is a real risk, and it almost never shows up in a deal memo. It shows up in month two of ownership, when the person leaves, or the agency relationship ends, and nobody can explain why the account works. That’s the risk Dimension 6 of the Patient Marketing Diligence framework, Operating Resilience, is built to surface. It’s the difference between a marketing engine and a marketing person.
What Key Person Risk Looks Like in Practice
It rarely looks dramatic. It looks like a conversion tracking setup that only one person understands, a campaign structure with no written logic behind it, a spreadsheet of bid adjustments that lives on someone’s laptop, or a CRM integration that was built once and never documented.
The person might be an in-house marketing lead, the founder, a long-tenured office manager who “just handles the ads,” or an individual at the agency who happens to own the relationship. In each case the pattern is the same: performance exists, but the reasons for it live in one head.
Who Actually Controls the Asset
The most important question isn’t who manages the accounts. It’s who owns them. In diligence, confirm that the practice’s own legal entity owns the Google Ads account, the Meta Business account, the analytics property, the call tracking account, and the CRM, and that more than one person at the practice has admin access.
It’s common to find the opposite: an ad account created under a former employee’s personal email, an analytics property owned by an agency, or a call tracking account that only the vendor can log into. Each of those turns a transition into a negotiation, and each is much easier to fix before close than after.
Documentation as a Maturity Signal
Documentation is a useful proxy for institutional maturity. A target with a written account structure, a conversion tracking map showing which actions feed which systems, a naming convention, and a record of major changes is a target whose performance can survive a handoff. A target with none of that may still perform well today, but the performance isn’t transferable in the way a buyer is assuming.
Contracts matter here as well. Check whether the agency agreement has transition or offboarding terms, notice periods, and a clause confirming the practice owns the accounts and data. The absence of those terms is a Soft Flag on its own.
Questions to Ask in One Diligence Call
A buyer can get most of the answer in a single call. Who has admin access to each platform, and under which email addresses? Who built the conversion tracking, and is it documented? If the current agency or lead left in 30 days, who could run the accounts, and how long would it take them to get up to speed? When was the last time someone other than the primary manager reviewed the account? How are changes to bids and budgets recorded?
Vague or hesitant answers to these questions are informative. So is a quick, specific answer backed by a document the target can send the same day.
Scoring It
The framework scores this dimension on structural resilience, from documented account structure, tracking, and processes with no dependence on any single individual at the top, down to total key-person dependency with no documentation and no access redundancy at the bottom. A score of 3 typically means some institutional knowledge is undocumented and a transition would cause a temporary dip in performance.
The Hard Flag is any ad account, analytics property, or CRM that the practice entity does not own, such as one sitting under a departing owner’s or an agency’s personal account. Soft Flags include conversion tracking that exists only in one person’s memory, and an agency contract with no offboarding clause.
Why It Matters for the Deal
This is integration risk, priced. If performance depends on a person who won’t be there after close, the buyer is paying for results that may not transfer, and carrying the cost of rebuilding the knowledge afterward. Resilience that’s verified in diligence supports the multiple. Fragility that’s found early can be fixed with an access transfer, a documentation sprint, or a retention agreement. Fragility found late is simply a surprise.
This is Dimension 6 of 7 in the Patient Marketing Diligence Framework, a standard for evaluating whether a healthcare target’s patient acquisition is built to last or bought to look good for a sale.
Get the full framework: all 7 dimensions, complete scoring criteria, evidence sourcing, and red flag triggers, delivered free.
